Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma?

Annals of Surgery

Volumn 254, Issue 2, 2011, Pages 383-

  Sapisochin, Gonzalo ^a,b   Yao, Francis Y ^b   Roberts, John P ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN;

CANCER INVASION; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); DISEASE FREE SURVIVAL; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFLAMMATION; LETTER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; NEUTROPHILIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PUBLICATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCIENTIFIC LITERATURE; TUMOR RECURRENCE; VASCULAR INVASION;

ACTUARIAL ANALYSIS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79961023721     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318226829f     Document Type: Letter

References (9)

1. Halazun KJ, Hardy MA, Rana AB, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250:141-151.
2. Walsh SR, Cook EJ, Goulder F, et al. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181-184. (Pubitemid 41254421)
3. Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008;34:55-60. (Pubitemid 350296756)
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699. (Pubitemid 26079803)
5. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007;11:2587-2596. (Pubitemid 47561609)
6. Balkwill F, Montovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-545. (Pubitemid 32173595)
7. Kusumanto YH, Daw WA, Hospers GA, et al. Platelets and granulocytes, in particular neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6:283-287. (Pubitemid 38987537)
8. Brodsky SV, Mendelev N, Melamed M, et al. Vascular density and VEGF expression in hepatic lesions. J Gastrointest Liver Dis. 2007;16:373-377.
9. Schwartz M, Dvorchik I, Roayaie S, et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol. 2008;49:581-588.